1.

Record Nr.

UNINA9910458987003321

Autore

Nemerov Alexander

Titolo

Acting in the night [[electronic resource] ] : Macbeth and the places of the Civil War / / Alexander Nemerov

Pubbl/distr/stampa

Berkeley, : University of California Press, c2010

ISBN

1-283-27728-X

9786613277282

0-520-94744-4

Descrizione fisica

1 online resource (313 p.)

Disciplina

792.0973/09034

Soggetti

Theater and society - Washington (D.C.) - History - 19th century

Theater - Washington (D.C.) - History - 19th century

Electronic books.

United States History Civil War, 1861-1865 Theater and the war

United States History Civil War, 1861-1865 Social aspects

Washington (D.C.) History Civil War, 1861-1865 Social aspects

Virginia History Civil War, 1861-1865 Social aspects

Washington (D.C.) Social conditions 19th century

Virginia Social conditions 19th century

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

"Ahmanson-Murphy fine arts imprint."

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Frontmatter -- Contents -- Introduction: A Drop That Dyes the Seas -- 1. A Stone's Throw: Charlotte Cushman -- 2. The Flame of Place: Abraham Lincoln -- 3. The Glass Case: Interior Life in Washington, D.C. -- 4. Acoustic Shadows: The Battle of Bristoe Station -- 5. Center of Echoes: Castle Murray, Fauquier County, Virginia -- 6. Ghosts: The Death of Colonel Thomas Ru‹n, October 17, 1863 -- 7. Sound and Fury: Nature in Virginia -- Acknowledgments -- Notes -- Selected Bibliography -- Illustrations -- Index

Sommario/riassunto

What can the performance of a single play on one specific night tell us about the world this event inhabited so briefly? Alexander Nemerov takes a performance of Macbeth in Washington, DC on October 17, 1863-with Abraham Lincoln in attendance-to explore this question and



illuminate American art, politics, technology, and life as it was being lived. Nemerov's inspiration is Wallace Stevens and his poem "Anecdote of the Jar," in which a single object organizes the wilderness around it in the consciousness of the poet. For Nemerov, that evening's performance of Macbeth reached across the tragedy of civil war to acknowledge the horrors and emptiness of a world it tried and ultimately failed to change.

2.

Record Nr.

UNINA9910557675503321

Autore

Diebold Yolanda

Titolo

Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges

Pubbl/distr/stampa

Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021

Descrizione fisica

1 online resource (207 p.)

Soggetti

Medicine and Nursing

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Sommario/riassunto

The concept of advanced therapy medicinal products (ATMPs) encompasses novel kinds of medicines for human use that are based on genes, cells or tissues. These intend to offer not only regeneration, but complete functional recovery of diseased tissues and organs using different strategies. Gene therapy, cell therapy and tissue engineering are the main areas in which promising advanced therapies are emerging. The eye is a very complex organ whose main structures, the cornea and the retina, play a pivotal role in maintaining normal vision, as severe alterations in these tissues can lead to blindness. Ocular tissues are starting to benefit from ATMPs by fighting against the enormous complexity and devastating potential of many ocular diseases. However, developments arising from this field of work face important challenges related to vectors to deliver drugs and genetic



material to target tissues, suitable biomaterials to prepare cell scaffolds and cell stemness, among others-not to mention the complicated legislation around ATMPs, the complexity in production and quality control and the absence of standardized protocols.The purpose of this Special Issue is to serve as an overview of the current progress in the application of cell and gene therapies, as well as tissue engineering to restore functionality in diseased ocular structures, and the challenges linked to reaching patients.